J Dambacher
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
Dambacher J, Beigel F, Zitzmann K, De Toni E, Göke B, Diepolder H, Auernhammer C, Brand S. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2008; 58:1207-17.
15.05.2008The role of the novel Th17 cytokine IL-26 in intestinal inflammation
15.05.2008Gut 2008; 58:1207-17
Dambacher J, Beigel F, Zitzmann K, De Toni E N, Göke B, Diepolder H M, Auernhammer C J, Brand Stephan
The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand S. The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens 2007; 70:238-46.
01.09.2007The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
01.09.2007Tissue Antigens 2007; 70:238-46
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H-P, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand Stephan
Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T. Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study. Aliment Pharmacol Ther 2007; 25:787-96.
01.04.2007Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
01.04.2007Aliment Pharmacol Ther 2007; 25:787-96
Seiderer J, Brand Stephan, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T
The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand S. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 24:1105-15.
01.10.2006The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
01.10.2006Aliment Pharmacol Ther 2006; 24:1105-15
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J-M, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand Stephan
The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
Brand S, Auernhammer C, Adler B, Diepolder H, Göke B, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells. Gastroenterology 2005; 129:371-371.
04.10.2005The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
04.10.2005Gastroenterology 2005; 129:371-371
Brand Stephan, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Göke B, Otte J-M, Eichhorst Soeren T, Zitzmann K, Olszak Torsten, Beigel F, Dambacher J